Cyxtera Results Presentation Deck

Transaction Adjusted EBITDA Bridge: Q4 2020 to Q4 2021 ($ in Millions) Cyxtera (1) (2) $47.2 Q4'20 +$5.7 Change in Revenue (2) -$0.2 Change in Cost of Revenue (2) + $0.8 Change in SG&A Includes pro forma EBITDA adjustments related to one-time stand-up costs, recurring expenses, restructuring & cost-savings initiatives, as well as product development & start-up costs. Excludes impact of Moses Lake -$5.4 Change in Adjustments (1)(2) $48.0 Q4'21 19

View entire presentation